CIRCULATING ENDOTHELIAL CELLS AND THEIR APOPTOTIC FRACTION ARE MUTUALLY INDEPENDENT PREDICTIVE BIOMARKERS IN BEVACIZUMAB-BASED TREATMENT FOR ADVANCED COLORECTAL CANCER.